Latest Market Challenges News

Qualitas Limited posted a 25% rise in net profit for FY26, driven by a 36% increase in fee earning funds under management and a strategic UK acquisition that expands its European presence.

WCM Global Growth reported a $66.7 million profit for FY2026, slightly down from last year, but boosted its final dividend and outlined a progressive dividend increase plan while completing a major $84.8 million capital raising.

Universal Store Holdings (ASX:UNI) posted a 12.9% revenue increase to $376.1 million in FY26, driven by strong like-for-like sales and store expansion. Underlying EBIT climbed 17.2% despite a $23.8 million impairment on CTC assets, while net profit after tax fell 21.6%. CEO Alice Barbery will retire in October, succeeded by George Do.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.

Ignite Limited reported an 18.8% drop in revenue to $73.2 million and a 29.4% fall in statutory profit to $0.87 million for FY2026, while maintaining a 13% gross margin and declaring a fully franked final dividend.

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

AGL Energy reported a 575% surge in statutory profit to $756 million for FY26, driven by strategic divestments and improved asset flexibility, while declaring a fully franked 50 cents dividend and progressing its energy transition with 12 GW of renewable capacity targeted by 2035.

Helia Group’s half-year profit fell 25% to $100 million, hit by lower premiums and investment income. The insurer declared a combined 43 cents per share dividend and launched a $75 million share buy-back.